These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15845543)

  • 1. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways.
    Shin Y; Klucken J; Patterson C; Hyman BT; McLean PJ
    J Biol Chem; 2005 Jun; 280(25):23727-34. PubMed ID: 15845543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
    Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
    J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
    Szargel R; Rott R; Eyal A; Haskin J; Shani V; Balan L; Wolosker H; Engelender S
    J Biol Chem; 2009 Apr; 284(17):11706-16. PubMed ID: 19224863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5).
    Kalia LV; Kalia SK; Chau H; Lozano AM; Hyman BT; McLean PJ
    PLoS One; 2011 Feb; 6(2):e14695. PubMed ID: 21358815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
    Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
    Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHIP: A Co-chaperone for Degradation by the Proteasome and Lysosome.
    Chakraborty A; Edkins AL
    Subcell Biochem; 2023; 101():351-387. PubMed ID: 36520313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation.
    McLean PJ; Kawamata H; Shariff S; Hewett J; Sharma N; Ueda K; Breakefield XO; Hyman BT
    J Neurochem; 2002 Nov; 83(4):846-54. PubMed ID: 12421356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein--implications for Parkinson's disease.
    Marx FP; Soehn AS; Berg D; Melle C; Schiesling C; Lang M; Kautzmann S; Strauss KM; Franck T; Engelender S; Pahnke J; Dawson S; von Eggeling F; Schulz JB; Riess O; Krüger R
    FASEB J; 2007 Jun; 21(8):1759-67. PubMed ID: 17327361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
    Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
    J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP targets toxic alpha-Synuclein oligomers for degradation.
    Tetzlaff JE; Putcha P; Outeiro TF; Ivanov A; Berezovska O; Hyman BT; McLean PJ
    J Biol Chem; 2008 Jun; 283(26):17962-8. PubMed ID: 18436529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation.
    Avraham E; Szargel R; Eyal A; Rott R; Engelender S
    J Biol Chem; 2005 Dec; 280(52):42877-86. PubMed ID: 16174773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.
    Klucken J; Shin Y; Hyman BT; McLean PJ
    Biochem Biophys Res Commun; 2004 Dec; 325(1):367-73. PubMed ID: 15522241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.
    Xia T; Dimitropoulou C; Zeng J; Antonova GN; Snead C; Venema RC; Fulton D; Qian S; Patterson C; Papapetropoulos A; Catravas JD
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3080-7. PubMed ID: 17873020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHIP: a co-chaperone for degradation by the proteasome.
    Edkins AL
    Subcell Biochem; 2015; 78():219-42. PubMed ID: 25487024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.
    Tanji K; Tanaka T; Mori F; Kito K; Takahashi H; Wakabayashi K; Kamitani T
    Am J Pathol; 2006 Aug; 169(2):553-65. PubMed ID: 16877356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.